Marcus Schindler

No open positions remaining

59 year

Health Technology

Consumer Services

Profile

Marcus Schindler is Chief Scientific Officer & Executive VP-Research at Novo Nordisk A. He received a doctorate from the University of Cambridge.

29/07/25	Novo Nordisk appoints Maziar Mike Doustdar as president, CEO	RE
07/02/25	Novo Nordisk's Head of Research Marcus Schindler sells shares for DKK 25 million	FW

Companies	Position	End
NOVO NORDISK A/S	Chief Tech/Sci/R&D Officer	06/08/2025
INNATE PHARMA	Director/Board Member	27/05/2021
AstraZeneca A/S (Denmark) AstraZeneca A/S (Denmark) Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical medicines	Corporate Officer/Principal	30/11/2017
Prosidion Ltd. Prosidion Ltd. Pharmaceuticals: MajorHealth Technology Manufactures products for treatment of metabolic diseases	Chief Tech/Sci/R&D Officer	31/12/2011

Active

Inactive

Listed companies

Private companies

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

Private companies	6
Novo Nordisk A/S Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care	Health Technology
University of Cambridge University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Innate Pharma SA Innate Pharma SA Pharmaceuticals: MajorHealth Technology Develops therapeutic antibodies that harness the immune system to improve cancer treatment and clinical outcomes	Health Technology
Prosidion Ltd. Prosidion Ltd. Pharmaceuticals: MajorHealth Technology Manufactures products for treatment of metabolic diseases	Health Technology
University of Gottingen University of Gottingen Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
AstraZeneca A/S (Denmark) AstraZeneca A/S (Denmark) Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical medicines	Health Technology